Saltar al contenido
PivotalWire
Viernes 30 oct 2026SEC · NASDAQ biomédico

Omaveloxolone

Omaveloxolone es un fármaco en desarrollo de Biogen. Tiene 20 ensayos clínicos registrados, 4 en marcha; lo más avanzado, no aplica.

BIIB Biogen

Sus ensayos

Para quéFaseEstado
Ataxia de Friedreich NCT06953583Fase 3En marcha, sin reclutar
Ataxia de Friedreich NCT06623890no aplicaReclutando pacientes
Ataxia de Friedreich NCT06054893Fase 1En marcha, sin reclutar
Ataxia de Friedreich NCT06628687no aplicaReclutando pacientes
A Study to Learn How the Body Processes BIIB141 (Omaveloxolone) When Taken as a Capsule or as a Tablet Dissolved in Liquid, and to Learn About Its Safety in Healthy Adults Ages 18 to 55 NCT07297199Fase 1Completado
A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55 NCT07149415Fase 1Completado
A Study to Learn How BIIB141 (Omaveloxolone) is Processed in the Body When Taken as Capsules Compared to Sprinkled on Yogurt in Healthy Adults Aged 18 to 55 NCT07019064Fase 1Completado
A Study to Find Out How BIIB141 (Omaveloxolone) Moves From the Blood Into the Breastmilk of Healthy Women Who Are Breastfeeding or Pumping Milk NCT06612879Fase 1Completado
A TQTc Study for Omaveloxolone NCT05927649Fase 1Completado
An Open-label DDI Study of Omaveloxolone in Healthy Subjects NCT05909644Fase 1Completado
Insuficiencia hepática NCT03902002Fase 1Completado
Ataxia de Friedreich NCT02255435Fase 2Completado
A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone NCT04008186Fase 1Completado
A Pharmacokinetic Study of Omaveloxolone in Healthy Volunteers NCT03664453Fase 1Completado
Melanoma NCT02259231Fase 1/2Completado
RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR NCT02255422Fase 2Completado
DISCOVER NCT02029729Fase 1Completado
RTA 408 Ophthalmic Suspension for the Prevention of Corneal Endothelial Cell Loss Following Cataract Surgery - GUARD NCT02128113Fase 2Completado
RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery NCT02065375Fase 2Completado
Melanoma NCT03593499no aplicaYa no disponible

¿Cuándo se esperan resultados? Está en el calendario, para quien tiene cuenta. Crear una cuenta.

Ensayos del registro público de ClinicalTrials.gov; noticias, de los documentos que la empresa presenta ante la SEC. No son recomendaciones de inversión.